Arcadia Biosciences, Inc. (RKDA) Free cash flow 2017–2025
Arcadia Biosciences, Inc. (RKDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.6MFY2025 · since FY2017: -$17.1M → -$9.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.6M | +37.1% |
| FY2024 | -$15.3M | -9.5% |
| FY2023 | -$14.0M | +46.1% |
| FY2022 | -$25.9M | +16.9% |
| FY2021 | -$31.2M | -59.9% |
| FY2020 | -$19.5M | -29.3% |
| FY2019 | -$15.1M | -6.3% |
| FY2018 | -$14.2M | +17.0% |
| FY2017 | -$17.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice